Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Acute Myeloid Leukemia,Leukemia Cutis,Myeloid Neoplasm,Myeloid Sarcoma
Study Phase
Phase 3
Study Completion Date
March 2019
NCT01371981Uploaded 03-24-2021
Access via NCI by Request
PDS UID: nci-data-461
A Phase III Randomized Trial for Patients With De Novo AML Using Bortezomib and Sorafenib (NSC# 681239, NSC# 724772) for Patients With High Allelic Ratio FLT3/ITD
Files: NCT01371981-D4
Data DictionaryNCT01371981-D4-Data-Dictionary_1.pdf
DATANCT01371981-D4-Dataset.csv
OTHERREADME.pdf